NCT05368857View on ClinicalTrials.gov

DNA Repair Capacity of Afamelanotide on Ultraviolet Radiation-induced DNA Damage in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 19, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

February 1, 2023

Conditions
Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
Interventions
DRUG

Afamelanotide

Up to 10 adult healthy volunteers will be enrolled in this study in which small areas of their skin will be exposed to UVR and skin samples taken. UV-induced DNA damage and repair will be analysed.

Trial Locations (1)

Unknown

CLINUVEL Investigational Site, Clinuvel Investigational Site

All Listed Sponsors
lead

Clinuvel (UK) Ltd.

INDUSTRY